532
Views
3
CrossRef citations to date
0
Altmetric
Cardiovascular

Resource utilization and charges of patients with and without diagnosed venous thromboembolism during primary hospitalization and after elective inpatient surgery: a retrospective study

, , , , , & show all
Pages 595-602 | Received 26 Sep 2017, Accepted 22 Feb 2018, Published online: 01 Mar 2018

References

  • Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol 2015;12:464-74
  • Naess IA, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007;5:692-9
  • Beckman MG, Hooper C, Critchley SE, et al. Venous thromboembolism: a public health concern. Am J Prev Med 2010;38:S495-S501
  • Charen DA, Qian ET, Hutzler LH, et al. Risk factors for postoperative venous thromboembolism in orthopaedic spine surgery, hip arthroplasty, and knee arthroplasty patients. Bull Hosp Joint Dis 2015;73:198-203
  • Jaffer AK, Barsoum WK, Krebs V, et al. Duration of anesthesia and venous thromboembolism after hip and knee arthroplasty. Mayo Clin Proc 2005;80:732-8
  • Wolberg AS, Aleman MM, Leiderman K, et al. Procoagulant activity in hemostasis and thrombosis: Virchow’s trial revisited. Anesth Analg 2012;114:275-85
  • Nelson RE, Grosse SD, Waitzman NJ, et al. Using multiple sources of data for surveillance of postoperative venous thromboembolism among surgical patients treated in Department of Veterans Affairs hospitals, 2005–2010. Thromb Res 2015;135:636-42
  • Amin A, Bruno A, Trocio J, et al. Incremental health care burden of bleeding among patients with venous thromboembolism in the United States. J Manag Care Spec Pharm 2015;21:965-72
  • Sanfilippo KM, Wang TF, Gage BF, et al. Improving accuracy of international classification of diseases codes for venous thromboembolism in administrative data. Thromb Res 2015;135:616-20
  • Fang MC, Fan D, Sung SH, et al. Validity of using inpatient and outpatient administrative codes to identify acute venous thromboembolism: the CVRN VTE study. Med Care 2017;55:e137-e143
  • Boulet SL, Grosse SD, Hooper WC, et al. Prevalence of venous thromboembolism among privately insured US adults. Arch Intern Med 2015;170:1774-5
  • Assareh H, Chen J, Ou L, et al. Rate of venous thromboembolism among surgical patients in Australian hospitals: a multicenter retrospective cohort study. BMJ 2014;4:e005502
  • White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 2003;90:446-55
  • Mukherjee D, Lidor AO, Chu KM, et al. Postoperative venous thromboembolism rates vary significantly after different types of major abdominal operations. J Gastrointest Surg 2008;12:2015-22
  • Becattini C, Rondelli F, Vedovati MC, et al. Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer. Haematologica 2015;100:e35
  • Kearon C, Akl EA, Omelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016;149:315-52
  • Cohoon KP, Leibson CL, Ransom JE, et al. Costs of venous thromboembolism association with hospitalization for medical illness. Am J Manag Care 2015;21:e255-e263
  • Bohensky MA, Ademi Z, deSteiger R, et al. Quantifying the excess cost and resource utilization for patients with complications associated with elective knee arthroscopy: a retrospective cohort study. The Knee 2014;21:491-6
  • Shahi A, Chen AF, Tan TL, et al. The incidence and economic burden of in-hospital venous thromboembolis in the United States. J Arthroplasty 2016;xxx:1-4
  • Fanikos J, Rao A, Seger AC, et al. Hospital costs of acute pulmonary embolism. Am J Med 2013;126:127-32
  • Dobesh PP. Economic implications of inadequate treatment of venous thromboembolism and potential solutions. J Pharm Pract 2014;27:178-86
  • The Surgeon General’s call to action to prevent deep vein thrombosis and pulmonary embolism. National Heart, Lung, and Blood Institute (US). Rockville (MD): Office of the Surgeon General; 2008. Available at: https://www.ncbi.nlm.nih.gov/books/NBK44183/
  • Canadian Agency for Drugs and Technologies in Health. Effectiveness of factor V Leiden and prothrombin mutation testing in patients presenting with a first unprovoked venous thromboembolic episode: a systematic review and economic analysis [Internet]. Ottawa: The Agency; 2015 (CADTH Optimal Use Report vol. 4, no. 1a). Available at: http://www.cadth.ca/media/pdf/OP0517 Thrombophilia Science Report.pdf
  • Roldan V, Lecumberri R, Sanchez JF, et al. Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. Thromb Res 2009;124:174-7
  • Rubio-Terres C, Soria JM, Morange PE, et al. Economic analysis of Thrombo inCode, a clinical-genetic function for assessing the risk of venous thromboembolism. Appl Health Econ Health Policy 2015;13:233-42

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.